VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析

◆英語タイトル:VolitionRX Ltd (VNRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME321317FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.

VolitionRX Ltd Key Recent Developments

Mar 30,2021: VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary
Mar 29,2021: VolitionRx appoints two new directors
Mar 22,2021: VolitionRx announces Full Fiscal Year 2020 Financial Results and Business Update
Mar 16,2021: VolitionRx Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
Mar 08,2021: VolitionRx Limited to Present at Conferences in March 2021

This comprehensive SWOT profile of VolitionRX Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of VolitionRX Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

VolitionRX Ltd – Key Information
VolitionRX Ltd – Overview
VolitionRX Ltd – Key Employees
VolitionRX Ltd – Key Employee Biographies
VolitionRX Ltd – Key Operational Heads
VolitionRX Ltd – Major Products and Services
VolitionRX Ltd – History
VolitionRX Ltd – Company Statement
VolitionRX Ltd – Locations And Subsidiaries
VolitionRX Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

VolitionRX Ltd – Business Description
VolitionRX Ltd – Corporate Strategy
VolitionRX Ltd – SWOT Analysis
SWOT Analysis – Overview
VolitionRX Ltd – Strengths
VolitionRX Ltd – Weaknesses
VolitionRX Ltd – Opportunities
VolitionRX Ltd – Threats
VolitionRX Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

VolitionRX Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

VolitionRX Ltd, Key Information
VolitionRX Ltd, Key Ratios
VolitionRX Ltd, Share Data
VolitionRX Ltd, Major Products and Services
VolitionRX Ltd, History
VolitionRX Ltd, Key Employees
VolitionRX Ltd, Key Employee Biographies
VolitionRX Ltd, Key Operational Heads
VolitionRX Ltd, Other Locations
VolitionRX Ltd, Subsidiaries
VolitionRX Ltd, Key Competitors
VolitionRX Ltd, SWOT Analysis
VolitionRX Ltd, Ratios based on current share price
VolitionRX Ltd, Annual Ratios
VolitionRX Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innospec Inc (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company offers products such as tenapanor, and RDX013. Its products are used for hyperphosphatemia in patients with end-stage renal disease; consti …
  • AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報
    Summary AstraZeneca KK (AstraZeneca) a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic dise …
  • Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Aderans Co Ltd:企業の戦略・SWOT・財務情報
    Aderans Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Aderans Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AGF Management Ltd:企業の戦略・SWOT・財務分析
    AGF Management Ltd - Strategy, SWOT and Corporate Finance Report Summary AGF Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Kala Pharmaceuticals Inc (KALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company that offers nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III …
  • The Carlyle Group LP (CG):企業の財務・戦略的SWOT分析
    The Carlyle Group LP (CG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Brake Bros Ltd:企業の戦略的SWOT分析
    Brake Bros Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Genedrive Plc (GDR):企業の財務・戦略的SWOT分析
    Genedrive Plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Concho Resources Inc.:戦略・SWOT・企業財務分析
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Genesee BioMedical Inc-医療機器分野:企業M&A・提携分析
    Summary Genesee BioMedical Inc (Genesee BioMedical) is a medical device company that provides medical and surgical instruments. The company’s products include coronary bypass graft markers, pediatric and adult cardiac surgical instruments, off-pump CABG devices, adult thoracic retractors, and cardia …
  • Trina Solar Ltd-エネルギー分野:企業M&A・提携分析
    Summary Trina Solar Ltd (Trina Solar) is a vertically-integrated solar power products manufacturer. The company manufactures a wide variety of PV modules, both monocrystalline and multicrystalline; ingots, wafers, cells and solar modules. The company also designs, constructs, sells and operates sola …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nevro Corp (NVRO)-医療機器分野:企業M&A・提携分析
    Summary Nevro Corp (Nevro) is a medical device company that offers therapeutic equipment. The company provides pain relief therapies for low back pain and other types of chronic pain. Its services include SCS therapy and clinical trials. Nevro’s SCS therapy is a low-frequency spinal cord stimulation …
  • American Bio Medica Corp (ABMC):企業の財務・戦略的SWOT分析
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, Rapid One, and Rapid Drug Screen, among others. It offers OralStat used for the detection of drugs in oral fluids. ABMC also pro …
  • Nexgenia Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and cell separations for diagnostic and lif …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆